83 related articles for article (PubMed ID: 30139518)
1. Target identification of hepcidin production inhibitors by a combination of chemical proteomics and radioactive compound binding assay.
Sasaki M; Ueda K; Fukuda T; Tanaka N; Shimizu H; Kubota K
Biochem Biophys Res Commun; 2018 Sep; 503(4):2878-2884. PubMed ID: 30139518
[TBL] [Abstract][Full Text] [Related]
2. The type I BMP receptor Alk3 is required for the induction of hepatic hepcidin gene expression by interleukin-6.
Mayeur C; Lohmeyer LK; Leyton P; Kao SM; Pappas AE; Kolodziej SA; Spagnolli E; Yu B; Galdos RL; Yu PB; Peterson RT; Bloch DB; Bloch KD; Steinbicker AU
Blood; 2014 Apr; 123(14):2261-8. PubMed ID: 24501215
[TBL] [Abstract][Full Text] [Related]
3. Discovery of DS79182026: A potent orally active hepcidin production inhibitor.
Fukuda T; Goto R; Kiho T; Ueda K; Muramatsu S; Hashimoto M; Aki A; Watanabe K; Tanaka N
Bioorg Med Chem Lett; 2017 Aug; 27(16):3716-3722. PubMed ID: 28705644
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and SAR studies of 3,6-disubstituted indazole derivatives as potent hepcidin production inhibitors.
Fukuda T; Ueda K; Ishiyama T; Goto R; Muramatsu S; Hashimoto M; Watanabe K; Tanaka N
Bioorg Med Chem Lett; 2017 May; 27(10):2148-2152. PubMed ID: 28377056
[TBL] [Abstract][Full Text] [Related]
5. Discovery of DS28120313 as a potent orally active hepcidin production inhibitor: Design and optimization of novel 4,6-disubstituted indazole derivatives.
Fukuda T; Goto R; Kiho T; Ueda K; Muramatsu S; Hashimoto M; Aki A; Watanabe K; Tanaka N
Bioorg Med Chem Lett; 2017 Dec; 27(23):5252-5257. PubMed ID: 29079471
[TBL] [Abstract][Full Text] [Related]
6. Discovery of DS42450411 as a potent orally active hepcidin production inhibitor: Design and optimization of novel 4-aminopyrimidine derivatives.
Fukuda T; Ishiyama T; Katagiri T; Ueda K; Muramatsu S; Hashimoto M; Aki A; Baba D; Watanabe K; Tanaka N
Bioorg Med Chem Lett; 2018 Nov; 28(20):3333-3337. PubMed ID: 30217414
[TBL] [Abstract][Full Text] [Related]
7. The immunophilin FKBP12 inhibits hepcidin expression by binding the BMP type I receptor ALK2 in hepatocytes.
Colucci S; Pagani A; Pettinato M; Artuso I; Nai A; Camaschella C; Silvestri L
Blood; 2017 Nov; 130(19):2111-2120. PubMed ID: 28864813
[TBL] [Abstract][Full Text] [Related]
8. A low-molecular-weight compound K7174 represses hepcidin: possible therapeutic strategy against anemia of chronic disease.
Fujiwara T; Ikeda T; Nagasaka Y; Okitsu Y; Katsuoka Y; Fukuhara N; Onishi Y; Ishizawa K; Ichinohasama R; Tomosugi N; Harigae H
PLoS One; 2013; 8(9):e75568. PubMed ID: 24086573
[TBL] [Abstract][Full Text] [Related]
9. Non-Anticoagulant Heparins Are Hepcidin Antagonists for the Treatment of Anemia.
Poli M; Asperti M; Ruzzenenti P; Naggi A; Arosio P
Molecules; 2017 Apr; 22(4):. PubMed ID: 28397746
[TBL] [Abstract][Full Text] [Related]
10. Pentosan polysulfate to control hepcidin expression in vitro and in vivo.
Asperti M; Denardo A; Gryzik M; Castagna A; Girelli D; Naggi A; Arosio P; Poli M
Biochem Pharmacol; 2020 May; 175():113867. PubMed ID: 32088260
[TBL] [Abstract][Full Text] [Related]
11. Momelotinib inhibits ACVR1/ALK2, decreases hepcidin production, and ameliorates anemia of chronic disease in rodents.
Asshoff M; Petzer V; Warr MR; Haschka D; Tymoszuk P; Demetz E; Seifert M; Posch W; Nairz M; Maciejewski P; Fowles P; Burns CJ; Smith G; Wagner KU; Weiss G; Whitney JA; Theurl I
Blood; 2017 Mar; 129(13):1823-1830. PubMed ID: 28188131
[TBL] [Abstract][Full Text] [Related]
12. Homocysteine upregulates hepcidin expression through BMP6/SMAD signaling pathway in hepatocytes.
Luo X; Luo Z; Zhang Z; Yang H; Lai B; Yao Q; Xiao L; Wang N
Biochem Biophys Res Commun; 2016 Mar; 471(2):303-8. PubMed ID: 26855134
[TBL] [Abstract][Full Text] [Related]
13. Oversulfated heparins with low anticoagulant activity are strong and fast inhibitors of hepcidin expression in vitro and in vivo.
Poli M; Asperti M; Ruzzenenti P; Mandelli L; Campostrini N; Martini G; Di Somma M; Maccarinelli F; Girelli D; Naggi A; Arosio P
Biochem Pharmacol; 2014 Dec; 92(3):467-75. PubMed ID: 25241290
[TBL] [Abstract][Full Text] [Related]
14. Identification of Guanosine 5'-diphosphate as Potential Iron Mobilizer: Preventing the Hepcidin-Ferroportin Interaction and Modulating the Interleukin-6/Stat-3 Pathway.
Angmo S; Tripathi N; Abbat S; Sharma S; Singh SS; Halder A; Yadav K; Shukla G; Sandhir R; Rishi V; Bharatam PV; Yadav H; Singhal NK
Sci Rep; 2017 Jan; 7():40097. PubMed ID: 28054602
[TBL] [Abstract][Full Text] [Related]
15. Kynurenine, by activating aryl hydrocarbon receptor, decreases erythropoietin and increases hepcidin production in HepG2 cells: A new mechanism for anemia of inflammation.
Eleftheriadis T; Pissas G; Antoniadi G; Liakopoulos V; Stefanidis I
Exp Hematol; 2016 Jan; 44(1):60-7.e1. PubMed ID: 26325330
[TBL] [Abstract][Full Text] [Related]
16. Regulation of hepcidin expression by inflammation-induced activin B.
Kanamori Y; Sugiyama M; Hashimoto O; Murakami M; Matsui T; Funaba M
Sci Rep; 2016 Dec; 6():38702. PubMed ID: 27922109
[TBL] [Abstract][Full Text] [Related]
17. [Inhibition effect of rhEPO on rhIL6-induced hepcidin mRNA expression in HepG2 cell lines and human primary hepatocytes].
Meng C; Zhou DB; Zhao YQ; Wang X; Gu B; Liu XQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1413-7. PubMed ID: 19099655
[TBL] [Abstract][Full Text] [Related]
18. Hepcidin in tumor-related iron deficiency anemia and tumor-related anemia of chronic disease: pathogenic mechanisms and diagnosis.
Shu T; Jing C; Lv Z; Xie Y; Xu J; Wu J
Eur J Haematol; 2015 Jan; 94(1):67-73. PubMed ID: 24954786
[TBL] [Abstract][Full Text] [Related]
19. Sustained plasma hepcidin suppression and iron elevation by Anticalin-derived hepcidin antagonist in cynomolgus monkey.
Hohlbaum AM; Gille H; Trentmann S; Kolodziejczyk M; Rattenstetter B; Laarakkers CM; Katzmann G; Christian HJ; Andersen N; Allersdorfer A; Olwill SA; Meibohm B; Audoly LP; Swinkels DW; van Swelm RPL
Br J Pharmacol; 2018 Apr; 175(7):1054-1065. PubMed ID: 29329501
[TBL] [Abstract][Full Text] [Related]
20. Characterization of hepcidin response to holotransferrin in novel recombinant TfR1 HepG2 cells.
Mehta K; Busbridge M; Renshaw D; Evans RW; Farnaud S; Patel VB
Blood Cells Mol Dis; 2016 Oct; 61():37-45. PubMed ID: 27667164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
